Avacta* (AVCT): Research collaboration with FIT Biotech (CORP) | Redcentric* (RCN): New CEO, trading update highlights strong cash flow (CORP) | Intercede* (IGP): Interim trading update (CORP)
05 Oct 2017
Morning Note
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
- Published:
05 Oct 2017 -
Author:
Andrew Darley | Mark Brewer | Cavendish Research -
Pages:
5
Avacta* (AVCT): Research collaboration with FIT Biotech (CORP) | Redcentric* (RCN): New CEO, trading update highlights strong cash flow (CORP) | Intercede* (IGP): Interim trading update (CORP)